Frequent Visits to Green Spaces Linked to Lower Use of Some Meds

Frequent visits to green spaces such as parks and community gardens are associated with a reduced use of certain prescription medications among city dwellers, a new analysis suggests. In a cross-sectional cohort study, frequent green space visits were associated with less frequent use of psychotropic, antihypertensive, and asthma medications in urban environments. Viewing green or … Read more

Even Low-Level Air Pollution Ups Depression, Anxiety Risk

Long-term exposure to multiple air pollutants is associated with a significantly increased risk for depression and anxiety, new research suggests. Analysis of nearly 400,000 people in the United Kingdom who were followed for a decade showed that even low levels of small particulate matter (PM), nitrogen dioxide (NO)2), and nitric oxide (NO) increased depression risk … Read more

Autism Found Detrimental to Cardiovascular Health

People with autism are more likely to face diabetes, high cholesterol, and heart disease than those without the neurological condition, according to a new study published this week in JAMA Pediatrics. Researchers also found that children with autism are especially likely to develop diabetes compared to their peers, and are at greater risk of hypertension, … Read more

TMS Tied to Antidepressant, Anxiolytic Effects in Anxious Depression

Transcranial magnetic stimulation (TMS) is associated with both anxiolytic and antidepressant effects in patients with anxious depression, new research suggests. In an analysis of data from more than 1,800 patients with a diagnosis of major depressive disorder (MDD), more than 75% also had anxiety. Following TMS, those with anxious depression showed reductions from baseline of … Read more

Depression Guidelines Fall Short in Characterizing Withdrawal

Current depression guidelines offer incomplete guidance for clinicians to identify antidepressant withdrawal, based on data from a review of 21 guidelines. Previous research suggests that approximately half of patients who discontinue or decrease dosage of antidepressants experience withdrawal symptoms, wrote Anders Sørensen, MD, of Copenhagen University Hospital, and colleagues. These symptoms are diverse and may … Read more

Noninvasive Laser Therapy Tied to Improved Short-Term Memory

Transcranial photobiomodulation (tPBM), a noninvasive laser light therapy, can improve short-term memory in young adults when applied to the right prefrontal cortex (PFC) of the brain, new research suggests. Investigators compared the effect of 1064 nm of tPBM delivered over a 12-minute session to the right PFC vs three other treatment arms: delivery of the … Read more

Highly Processed Foods ‘as Addictive’ as Tobacco

LONDON — Highly processed foods meet the same criteria as tobacco for addiction, and labeling them as such might benefit public health, according to a new US study that proposes a set of criteria to assess the addictive potential of some foods. The research suggests that healthcare professionals are taking steps towards framing food addiction … Read more

Single Dose of Psilocybin for Major Depression Tied to Short-Term Remission

A single 25 mg dose of synthetic psilocybin in combination with psychotherapy appears to effectively ease symptoms of treatment-resistant depression (TRD) — at least in the short-term, new research shows. In the largest study of psilocybin for TRD to-date, results of the phase 2b randomized, double-blind trial show participants in the 25-mg dose group experienced … Read more

It’s Just a Superstition — but Is It Harmless?

Airports typically exclude Gate 13. Some buildings skip the 13th floor. And Friday the 13th is not known as a lucky day. The fear of the number 13 is a superstition with a complicated name — triskaidekaphobia. The idea the number 13 is unlucky isn’t rational, of course, and for most, any unease about the … Read more

One Type of Older Diabetes Drug Cuts Dementia Risk, Another Ups It

Thiazolidinediones (TZDs), such as pioglitazone, appear to be protective against dementia whereas sulfonylureas appear to increase the risk, a new observational study in patients with type 2 diabetes suggests. The data, obtained from nationwide electronic medical from the US Veterans Affairs Administration, yielded a 22% lower risk of dementia with TZD monotherapy and a 12% … Read more